Pharmacologic and Hemodynamic Effects of Combined β-Agonist Stimulation and Phosphodiesterase Inhibition in the Failing Human Heart

This publication has 23 references indexed in Scilit:

• Arterial hemodynamics and cardiac effects of enoximone, dobutamine, and their combination in severe heart failure
  American Heart Journal, 1993
• Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
  Journal of Clinical Investigation, 1988
• New Positive Inotropic Agents in the Treatment of Congestive Heart Failure
  New England Journal of Medicine, 1986
• Acute hemodynamic effect of oral MDL 17,043 in severe congestive heart failure
  The American Journal of Cardiology, 1984
• Sensitivity and specificity of radionuclide ejection fractions in doxorubicin cardiotoxicity
  American Heart Journal, 1983
• Study of the normal and failing isolated human heart: Decreased response of failing heart to isoproterenol
  American Heart Journal, 1983
• The acute hemodynamic effects of a new agent, MDL 17,043, in the treatment of congestive heart failure.
  Circulation, 1983
• Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
  New England Journal of Medicine, 1982
• Biochemical Studies on the Mechanism of Cardiotonic Activity of MDL 17,043
  Journal of Cardiovascular Pharmacology, 1982
• Cardiovascular Properties of a New Cardiotonic Agent
  Journal of Cardiovascular Pharmacology, 1982